124 related articles for article (PubMed ID: 1271886)
1. Immunotherapy for accessible tumors utilizing delayed hypersensitivity reactions and separated components of the immune system.
Klein E; Holtermann O; Milgrom H; Case RW; Klein D; Rosner D; Djerassi I
Med Clin North Am; 1976 May; 60(3):389-418. PubMed ID: 1271886
[TBL] [Abstract][Full Text] [Related]
2. Responses of neoplasms to local immunotherapy.
Klein E; Holtermann OA; Case RW; Milgrom H; Rosner D; Adler S
Am J Clin Pathol; 1974 Aug; 62(2):281-9. PubMed ID: 4602090
[No Abstract] [Full Text] [Related]
3. Immunotherapeutic approaches to skin cancer.
Klein E
Hosp Pract; 1976 Nov; 11(11):107-16. PubMed ID: 1026608
[TBL] [Abstract][Full Text] [Related]
4. Nonspecific antigen reactions.
Klein E; Rosner D; Holtermann OA; Stoll HL; Song SY
Natl Cancer Inst Monogr; 1976 Nov; 44():87-97. PubMed ID: 799764
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapeutic approaches to the management of neoplasms.
Klein E; Holtermann OA
Natl Cancer Inst Monogr; 1972 Dec; 35():379-402. PubMed ID: 4572833
[No Abstract] [Full Text] [Related]
6. Experiences with local chemotherapy and immunotherapy in premalignant and malignant skin lesions.
Williams AC; Klein E
Cancer; 1970 Feb; 25(2):450-62. PubMed ID: 5413514
[No Abstract] [Full Text] [Related]
7. Immunologic approaches to the management of primary and secondary tumors involving the skin and soft tissues: review of a ten-year program.
Klein E; Holtermann OA; Helm F; Rosner D; Milgrom H; Adler S; Stoll HL; Case RW; Prior RL; Murphy GP
Transplant Proc; 1975 Jun; 7(2):297-315. PubMed ID: 1093298
[No Abstract] [Full Text] [Related]
8. Proceedings: Chemotherapy and immunotherapy for cancer involving the skin.
Klein E
Proc Natl Cancer Conf; 1972; 7():567-78. PubMed ID: 4764924
[No Abstract] [Full Text] [Related]
9. Regression of cutaneous neoplasms following delayed-type hypersensitivity challenge reactions to microbial antigens or lymphokines.
Holtermann OA; Papermaster B; Rosner D; Milgrom H; Klein E
J Med; 1975; 6(2):157-68. PubMed ID: 1099159
[TBL] [Abstract][Full Text] [Related]
10. Delayed hypersensitivity-induced regression of human neoplasms.
Stjernswärd J; Levin A
Cancer; 1971 Sep; 28(3):628-40. PubMed ID: 4938247
[No Abstract] [Full Text] [Related]
11. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.
Bluming AZ; Vogel CL; Ziegler JL; Kiryabwire JW
J Natl Cancer Inst; 1972 Jan; 48(1):17-24. PubMed ID: 4652371
[No Abstract] [Full Text] [Related]
12. [Local immunotherapy. Alternative therapy for malignant cutaneous lesions (demonstration on 30 patients with malignant melanoma) (author's transl)].
Kokoschka EM; Micksche M
Wien Klin Wochenschr; 1979 Mar; 91(5):150-4. PubMed ID: 425533
[TBL] [Abstract][Full Text] [Related]
13. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
Trapeznikov NN; Iavorskiĭ VV; Kadagidze ZG; Malaev SG; Kupin VI
Vopr Onkol; 1977; 23(8):27-33. PubMed ID: 906404
[TBL] [Abstract][Full Text] [Related]
14. Topical chemotherapy and immunotherapy of mycosis fungoides: intermediate-term results.
Vonderheid EC; Van Scott EJ; Johnson WC; Grekin DA; Asbell SO
Arch Dermatol; 1977 Apr; 113(4):454-62. PubMed ID: 848974
[TBL] [Abstract][Full Text] [Related]
15. Immunologic approaches to various types of cancer with the use of BCG and purified protein derivatives.
Klein E; Holtermann OA; Papermaster B; Milgrom H; Rosner D; Klein L; Walker MJ; Zbar B
Natl Cancer Inst Monogr; 1973 Dec; 39():229-42. PubMed ID: 4595323
[No Abstract] [Full Text] [Related]
16. Feasibility study of active immunotherapy in patients with solid tumors.
Gerner RE; Moore GE
Cancer; 1976 Jul; 38(1):131-43. PubMed ID: 779950
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for nonmelanoma skin cancer: does it have a future?
Urosevic M; Dummer R
Cancer; 2002 Jan; 94(2):477-85. PubMed ID: 11900233
[TBL] [Abstract][Full Text] [Related]
18. The immunobiology of skin cancer.
Dellon AL; Potvin C; Chretien PB; Rogentine CN
Plast Reconstr Surg; 1975 Mar; 55(3):341-354. PubMed ID: 1078893
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of malignancy in humans. Current status.
Holmes EC; Eilber FR; Morton DL
JAMA; 1975 Jun; 232(10):1052-5. PubMed ID: 236402
[TBL] [Abstract][Full Text] [Related]
20. Antigenic alterations in tumors of epidermal origin.
Tosca A; Varelzidis A; Nicolis G; Hadzis J; Stratigos J; Capetanakis J
Cancer; 1980 May; 45(9):2284-90. PubMed ID: 7379027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
